Research Projects & Grants

For Profit Organization

• A multicenter, randomized, double-blind, active controlled study to compare the effect of 24 weeks treatment with vildagliptin 100 mg qd or metformin 1500 mg daily in elderly drug naïve patients with type 2 diabetes LAF237/vildagliptin Protocol number CLAF237A2398, Role: Investigator, Novartis Pharmaceuticals Corporation, (08/2007 - 08/2008) Status: Completed